248 related articles for article (PubMed ID: 12176249)
21. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres.
Jung T; Breitenbach A; Kissel T
J Control Release; 2000 Jul; 67(2-3):157-69. PubMed ID: 10825550
[TBL] [Abstract][Full Text] [Related]
22. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
Shao PG; Bailey LC
Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
[TBL] [Abstract][Full Text] [Related]
23. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
Selmin F; Blasi P; DeLuca PP
AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
[TBL] [Abstract][Full Text] [Related]
24. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
25. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
26. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
27. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
28. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
30. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
Pavanetto F; Genta I; Giunchedi P; Conti B
J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
[TBL] [Abstract][Full Text] [Related]
33. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
Zheng J; Hornsby PJ
Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable polymeric microcellular foams by modified thermally induced phase separation method.
Nam YS; Park TG
Biomaterials; 1999 Oct; 20(19):1783-90. PubMed ID: 10509188
[TBL] [Abstract][Full Text] [Related]
35. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
36. Stability of prostaglandin E(2) (PGE (2)) embedded in poly-D,L: -lactide-co-glycolide microspheres: a pre-conditioning approach for tissue engineering applications.
Watzer B; Zehbe R; Halstenberg S; James Kirkpatrick C; Brochhausen C
J Mater Sci Mater Med; 2009 Jun; 20(6):1357-65. PubMed ID: 19160024
[TBL] [Abstract][Full Text] [Related]
37. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres.
Perugini P; Genta I; Pavanetto F; Modena T; Maculotti K; Conti B
J Microencapsul; 2002; 19(5):591-602. PubMed ID: 12433302
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy.
Konan YN; Cerny R; Favet J; Berton M; Gurny R; Allémann E
Eur J Pharm Biopharm; 2003 Jan; 55(1):115-24. PubMed ID: 12551712
[TBL] [Abstract][Full Text] [Related]
40. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer.
Elkheshen S
J Microencapsul; 1996; 13(4):447-62. PubMed ID: 8808781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
